Clinical Trials Logo

Clinical Trial Summary

This study is being done to discover if there is a link between estrogen exposure and the severity of Fuchs Endothelial Corneal Disease. We are trying to understand if the decrease in estrogen levels in post-menopausal women may be a reason why FECD is seen more often in women than men.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04564378
Study type Observational
Source State University of New York at Buffalo
Contact
Status Active, not recruiting
Phase
Start date January 17, 2018
Completion date June 30, 2024

See also
  Status Clinical Trial Phase
Terminated NCT04527523 - Descemet Membrane Endothelial Keratoplasty vs. Descemet's Stripping With Endothelial Keratoplasty vs. Descemet Stripping Only
Completed NCT03763721 - The ADVISE Study: Advanced Visualization In Corneal Surgery Evaluation N/A
Recruiting NCT04191629 - Phase 1 Study to Evaluate the Safety and Tolerability of EO1404 in the Treatment of Corneal Edema Phase 1
Recruiting NCT05853978 - The Evaluation of Balanced Salt Solution During Cataract Surgery Phase 4
Recruiting NCT03575130 - Ripasudil 0.4% Eye Drops in Fuchs Endothelial Corneal Dystrophy Phase 2
Recruiting NCT04258787 - OCT in Fuchs' Dystrophy
Active, not recruiting NCT04894110 - Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema Phase 1
Completed NCT00346138 - A Comparison Between Full Thickness and Partial Thickness Corneal Transplantation for Corneal Edema N/A
Recruiting NCT05275972 - Descemet Endothelial Thickness Comparison Trial II Phase 3
Completed NCT04676737 - TTHX1114(NM141) in Combination With DWEK/DSO Phase 2
Recruiting NCT03619434 - Femtolaser Assisted Keratoplasty Versus Conventional Keratoplasty N/A
Recruiting NCT05636579 - Study to Assess Safety and Tolerability of Multiple Doses of EO2002 Phase 1